# Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment

> **NCT03063606** · PHASE2,PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 31 (actual)

## Conditions studied

- Binge-Eating Disorder
- Obesity

## Interventions

- **BEHAVIORAL:** Cognitive-Behavioral Therapy (CBT)
- **DRUG:** NB Medication (on-going from acute treatment)

## Key facts

- **NCT ID:** NCT03063606
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-05
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-12-16
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063606, "Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03063606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*